Physician profile
Mccall Helstrom
NPI 1265067888
$1,581.23
in general payments reported to CMS, 2019-2025
30 companies · $832 in 2025
The $832 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.24 · 2023: $360 · 2024: $310 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $224.45 | 2024-2025 | Apretude |
| Astrazeneca Pharmaceuticals LP | $172.80 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Exact Sciences Corporation | $127.40 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $125.94 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $109.16 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $77.41 | 2023-2024 | |
| Pfizer INC. | $77.10 | 2023-2025 | |
| Corium, LLC | $55.38 | 2024-2025 | Azstarys |
| Axsome Therapeutics, INC. | $55.19 | 2025 | Auvelity |
| Boston Scientific Corporation | $42.46 | 2023 | Moses 550 D\F\L |
| Hologic Sales and Service, LLC | $39.39 | 2025 | Aptima |
| Tris Pharma INC | $38.74 | 2025 | Dyanavel Xr |
| Novo Nordisk INC | $37.12 | 2023 | Wegovy, Rybelsus, Ozempic |
| Mayne Pharma Commercial LLC | $34.78 | 2025 | |
| Merck Sharp & Dohme LLC | $33.33 | 2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $32.91 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.94 | 2022-2024 | Trulance, Xifaxan |
| Currax Pharmaceuticals LLC | $30.71 | 2025 | Contrave |
| Janssen Pharmaceuticals, INC | $30.62 | 2023 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.49 | 2022 | |
| Amgen INC. | $23.39 | 2024 | Otezla, Repatha |
| Teva Pharmaceuticals USA, INC. | $20.13 | 2022 | |
| Antares Pharma, INC. | $19.68 | 2023 | Nocdurna, Tlando, Xyosted |
| Phadia US INC. | $18.54 | 2025 | Immunocap |
| Insightec,INC | $17.72 | 2025 | Exablate |
| Dexcom, INC. | $17.23 | 2023 | Dexcom G6 Transmitter |
| Bausch Health US, LLC | $16.73 | 2024 | Wellbutrin, Aplenzin |
| Exeltis, USA INC. | $15.11 | 2023 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $13.60 | 2023 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $12.78 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mccall Helstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.